Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2012, Article ID 162806, 8 pages
http://dx.doi.org/10.1155/2012/162806
Research Article

Detecting Early Biomechanical Effects of Zoledronic Acid on Femurs of Osteoporotic Female Rats

1Department of Orthopaedics and Trauma Surgery, Marilia State Medical School, FAMEMA, Marilia, SP 17519-030, Brazil
2Department of Surgery and Orthopaedics, Botucatu Medical School, UNESP, Botucatu, SP 18618-000, Brazil
3Department of Medical Education, Marilia State Medical School, FAMEMA, Marilia, SP 17519-030, Brazil

Received 3 June 2012; Revised 30 September 2012; Accepted 19 October 2012

Academic Editor: Jean Jacques Body

Copyright © 2012 Evandro Pereira Palacio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Meirik and P. J. Rowe, “Research on fertility regulation. Safety and efficacy of existing methods of fertility regulation,” in WHO—World Health Organization. Annual Technical Report 1998, pp. 151–169, WHO Press, Geneva, Switzerland, 1999. View at Google Scholar
  2. B. Borah, G. J. Gross, T. E. Dufresne, T. S. Smith, M. D. Cockman et al., “Three-dimensional microimaging (MRmI and mCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis,” Anatomical Record, vol. 265, pp. 101–110, 2001. View at Google Scholar
  3. OMS/WHO—World Health Organization, “Diet, nutrition and the prevention of chronic diseases,” Report of a Joint WHO/FAO Expert consultation. [WHO technical Report Series] 916, WHO Press, Geneva, Switzerland, 2003. View at Google Scholar
  4. A. M. Pinto Neto, A. Soares, A. A. Urbanetz, A. C. A. Souza, A. E. M. Ferrari, B. Amaral et al., “Consenso brasileiro de osteoporose 2002,” Revista Brasileira de Reumatologia, vol. 42, no. 6, pp. 343–354, 2002. View at Google Scholar
  5. T. V. Nguyen, J. Blangero, and J. A. Eisman, “Genetic epidemiological approaches to the search for osteoporosis genes,” Journal of Bone and Mineral Research, vol. 15, no. 3, pp. 392–401, 2000. View at Google Scholar · View at Scopus
  6. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, “Osteoporosis prevention, diagnosis, and therapy,” Journal of the American Medical Association, vol. 285, pp. 785–795, 2001. View at Google Scholar
  7. J. Li, S. Mori, Y. Kaji, T. Mashiba, J. Kawanishi, and H. Norimatsu, “Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats,” Journal of Bone and Mineral Research, vol. 14, no. 6, pp. 969–979, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Chen, J. Berenson, R. Vescio et al., “Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases,” Journal of Clinical Pharmacology, vol. 42, no. 11, pp. 1228–1236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Wenzel, R. Bartsch, D. Hussian et al., “Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome,” Supportive Care in Cancer, vol. 12, no. 9, pp. 678–681, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Pataki, K. Müller, J. R. Green, Y. F. Ma, Q. N. Li, and W. S. S. Jee, “Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment,” Anatomical Record, vol. 249, pp. 458–468, 1997. View at Google Scholar
  11. S. M. Cheer and S. Noble, “Zoledronic acid,” Drugs, vol. 61, no. 6, pp. 799–805, 2001. View at Google Scholar · View at Scopus
  12. M. Glatt, A. Pataki, G. P. Evans, S. B. Hornby, and J. R. Green, “Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid,” Osteoporosis International, vol. 15, no. 9, pp. 707–715, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. L. M. Wise, S. D. Waldman, M. Kasra et al., “Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog,” Calcified Tissue International, vol. 77, no. 6, pp. 367–375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. P. Palacio, E. M. Jabob, T. B. Campi, and S. S. Müller, “O zoledronato no tratamento da osteoporose umeral em ratas. Estudo prospectivo e randomizado,” Acta Ortopédica Brasileira, vol. 18, pp. 90–95, 2010. View at Google Scholar
  15. F. R. A. Pereira, R. C. Dutra, T. C. R. Olímpio, S. S. Müller, and E. P. Palacio, “Efeito do ácido zoledrônico em tíbias de ratas ooforectomizadas. Estudo prospectivo e randomizado,” Revista Brasileira de Ortopedia, vol. 44, pp. 61–68, 2009. View at Google Scholar
  16. S. S. Müller, E. C. Curcelli, T. Sardenberg, A. Zuccon, J. L. Crudis Jr., and C. R. Padovani, “Ánalise clínica e biomecânica do efeito do diclofenaco sódico na consolidação da fratura da tíbia no rato,” Acta Ortopédica Brasileira, vol. 4, pp. 197–204, 2004. View at Google Scholar
  17. B. A. Smith, G. A. Livesay, and S. L. Y. Woo, “Biology and biomechanics of the anterior cruciate ligament,” Clinics in Sports Medicine, vol. 12, no. 4, pp. 637–670, 1993. View at Google Scholar · View at Scopus
  18. E. L. Smith and D. M. Raab, “Osteoporosis and physical activity,” Acta Medica Scandinavica, vol. 220, no. 711, pp. 149–156, 1986. View at Google Scholar · View at Scopus
  19. N. Amanat, R. Brown, L. E. Bilston, and D. G. Little, “A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair,” Journal of Orthopaedic Research, vol. 23, no. 5, pp. 1029–1034, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. E. Dunford, K. Thompson, F. P. Coxon et al., “Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates,” Journal of Pharmacology and Experimental Therapeutics, vol. 296, no. 2, pp. 235–242, 2001. View at Google Scholar · View at Scopus
  21. L. M. Wise, S. D. Waldman, M. Kasra et al., “Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog,” Calcified Tissue International, vol. 77, no. 6, pp. 367–375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Amanat, R. Brown, L. E. Bilston, and D. G. Little, “A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair,” Journal of Orthopaedic Research, vol. 23, no. 5, pp. 1029–1034, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. E. Dunford, K. Thompson, F. P. Coxon et al., “Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates,” Journal of Pharmacology and Experimental Therapeutics, vol. 296, no. 2, pp. 235–242, 2001. View at Google Scholar · View at Scopus
  24. A. H. Burstein, D. T. Reilly, and M. Martens, “Aging of bone tissue: mechanical properties,” Journal of Bone and Joint Surgery A, vol. 58, no. 1, pp. 82–86, 1976. View at Google Scholar · View at Scopus
  25. X. E. Guo and S. A. Goldstein, “Vertebral trabecular bone microscopic tissue elastic modulus and hardness do not change in ovariectomized rats,” Journal of Orthopaedic Research, vol. 18, no. 2, pp. 333–336, 2000. View at Google Scholar · View at Scopus
  26. D. C. L. Carvalho and A. Cliquet, “Ação do ultra-som de baixa intensidade sobre ossos de ratas osteopênicas,” Acta Ortopédica Brasileira, vol. 11, pp. 17–24, 2003. View at Google Scholar